• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2400371 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2024-06-07 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CYSB2400095 重组人凝血酶 thrombin alfa Other Biological Products(3.2) Supplementary Application 2024-04-24 Suzhou Zelgen Biopharmaceuticals Co Ltd view
CYSB2400055 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(原15) Supplementary Application 2024-03-01 China Resources Boya Bio-pharmaceutical Group Co Ltd view
CYSB2400045 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) Supplementary Application 2024-02-24 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2400046 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) Supplementary Application 2024-02-24 Hualan Biological Engineering Chongqing Co Ltd view
CXSL2400019 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2024-01-10 Wuhan Biopharmaceutical Co Ltd of China National Pharmaceutical Group view
CXSS2300087 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2023-11-10 Lanzhou Lansheng Plasma-derived Biotheraples Co Ltd view
CXSL2300641 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2023-09-22 China National Pharmaceutical Group Guizhou Biopharmaceutical Co Ltd view
JTS2300032 抗凝血酶III Other Biological Products Disposable Import Drug Application 2023-06-09 view
CYHB2300719 凝血酶散 thrombin Lyophilized Chemical Drugs Supplementary Application 2023-04-10 Zhejiang Hacon Pharmaceutical Co Ltd view
CYHB2300722 凝血酶散 thrombin Lyophilized Chemical Drugs Supplementary Application 2023-04-10 Zhejiang Hacon Pharmaceutical Co Ltd view
CYHB2300721 凝血酶散 thrombin Lyophilized Chemical Drugs Supplementary Application 2023-04-10 Zhejiang Hacon Pharmaceutical Co Ltd view
CYHB2300720 凝血酶散 thrombin Lyophilized Chemical Drugs Supplementary Application 2023-04-10 Zhejiang Hacon Pharmaceutical Co Ltd view
CYHB2300253 凝血酶散 thrombin Lyophilized Chemical Drugs Supplementary Application 2023-02-09 Changchun Haiwang Biological Pharmaceutical Co Ltd view
CYHB2300254 凝血酶散 thrombin Lyophilized Chemical Drugs Supplementary Application 2023-02-09 Changchun Haiwang Biological Pharmaceutical Co Ltd view
CYHB2300255 凝血酶散 thrombin Lyophilized Chemical Drugs Supplementary Application 2023-02-09 Changchun Haiwang Biological Pharmaceutical Co Ltd view
CXSS2200091 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2022-11-18 Shenzhen Weiguang Biological Products Co Ltd view
CYSB2200245 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products Supplementary Application 2022-10-12 Shanghai RAAS Blood Products Co Ltd view
CYSB2200244 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products Supplementary Application 2022-10-12 Shanghai RAAS Blood Products Co Ltd view
CYHB2201759 凝血酶散 thrombin Lyophilized Chemical Drugs Supplementary Application 2022-09-27 view